clinical trial | Q30612 |
P3098 | ClinicalTrials.gov ID | NCT00096031 |
P6099 | clinical trial phase | phase II clinical trial | Q42824440 |
P17 | country | United States of America | Q30 |
P582 | end time | 2008-01-01 | |
P4135 | maximum age | 120 | |
P2899 | minimum age | 18 | |
P1132 | number of participants | 63 | |
P6153 | research site | Hackley Hospital Emergency heliport | Q61673570 |
University of Michigan | Q230492 | ||
Fred Hutchinson Cancer Research Center | Q1452369 | ||
Denver Health Medical Center | Q3023367 | ||
Barbara Ann Karmanos Cancer Institute | Q4858714 | ||
Munson Medical Center | Q6936903 | ||
Piedmont Hospital | Q7191520 | ||
Swedish Medical Center | Q7654755 | ||
Wilford Hall Medical Center | Q8001708 | ||
P580 | start time | 2004-10-01 | |
P8363 | study type | interventional study | Q78089383 |
P1476 | title | Cetuximab As Second Line Therapy In Patients With Metastatic Esophageal Cancer - Phase II |
Search more.